Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck KGaA Raises Low End Of Prior FY 2013 EPS Guidance-Conference Call


Monday, 20 May 2013 08:00am EDT 

Merck KGaA announced that for fiscal 2013 it is narrowing the guidance on earnings per share (EPS). Before the Company guided EPS to be between $8.2 to $9.0 and now it is further refine that to the range of $8.5 to $9.0. 

Company Quote

105.15
1.25 +1.20%
24 Apr 2015